🇺🇸 BioMarin Pharmaceutical Inc.
Forum topic · BMRN · Company page: financials, ownership and filings
Join the discussion on BioMarin Pharmaceutical Inc.
Loading…
Results announced on 2 November 2026
BioMarin Pharmaceutical Inc. announced results on 2 November 2026 (SEC Form 8-K, item 2.02).
For the quarter ended 30 September 2026: revenue of $1.0 billion (up 32% from a year earlier) and a net loss of $123 million.
Results announced on 6 October 2026
BioMarin Pharmaceutical Inc. announced results on 6 October 2026 (SEC Form 8-K, item 2.02).
For the quarter ended 30 September 2026: revenue of $1.0 billion (up 32% from a year earlier) and a net loss of $123 million.
Layoff notice: 117 people
A layoff at BioMarin Pharmaceutical Inc. was announced on 24 September 2026: 117 people affected in Novato, CA. It takes effect on 4 December 2026.
Source: State WARN notice.
Mutual funds: 431 funds hold $5.1 billion
431 mutual funds in 2 countries hold shares of BioMarin Pharmaceutical Inc. worth $5.1 billion, about 45.7% of the company (funds' newest reports, up to 31 July 2026).
Since their previous reports 213 funds added shares and 147 sold; on balance they bought $177 million. Share splits are not counted as trading.
Source: Automatic updates: SEC filings, regulators' notices and fund reports held on this site. Posts marked 🤖 are written automatically from official data and state no opinion. Member comments are their authors' views, shown after an editor's review; they are not investment advice.